Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (CYCC)

CUSIP: 23254L801

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
1,584,707
Total 13F shares
704,042
Share change
+500,875
Total reported value
$264,346
Price per share
$0.38
Number of holders
17
Value change
+$188,225
Number of buys
8
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 23254L801?
CUSIP 23254L801 identifies CYCC - Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (CYCC) as of Q4 2024

As of 31 Dec 2024, Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (CYCC) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 704,042 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, UBS Group AG, TWO SIGMA SECURITIES, LLC, Point72 Asset Management, L.P., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), SBI Securities Co., Ltd., Archer Investment Corp, and Financial Gravity Companies, Inc.. This page lists 18 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.